Class III -Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non-Small Cell Lung Cancer: Analysis of NCIC JBR.10 (Q57272633)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Class III -Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non-Small Cell Lung Cancer: Analysis of NCIC JBR.10 |
article |
Statements
Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10 (English)
Pascal Sève
Raymond Lai
Keyue Ding
Timothy Winton
Charles Butts
Laith Dabbagh
Sarit Aviel-Ronen
Lesley Seymour
Marlo Whitehead
Frances A Shepherd
Tony Reiman
1 February 2007